Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.
Worthington J, van Wifferen F, Sun Z, de Jonge L, Lew JB, Greuter MJE, van den Puttelaar R, Feletto E, Lansdorp-Vogelaar I, Coupé VMH, Ein Yong JH, Canfell K; I-PaRCS Consortium. Worthington J, et al. Among authors: van wifferen f. EClinicalMedicine. 2023 Jul 20;62:102081. doi: 10.1016/j.eclinm.2023.102081. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37538541 Free PMC article.
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse EFP, Lew JB, Greuter MJE, Smith HA, Feletto E, Yong JHE, Canfell K, Coupé VMH, Lansdorp-Vogelaar I; COVID-19 and Cancer Global Modelling Consortium working group 2. de Jonge L, et al. Among authors: van wifferen f. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3. Lancet Gastroenterol Hepatol. 2021. PMID: 33548185 Free PMC article.
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
van Wifferen F, de Jonge L, Worthington J, Greuter MJE, Lew JB, Nadeau C, van den Puttelaar R, Feletto E, Yong JHE, Lansdorp-Vogelaar I, Canfell K, Coupé VMH; COVID-19 and Cancer Global Modelling Consortium (CCGMC) working group 2. van Wifferen F, et al. J Med Screen. 2022 Jun;29(2):72-83. doi: 10.1177/09691413211056777. Epub 2021 Dec 3. J Med Screen. 2022. PMID: 35100894 Free PMC article.
Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening.
van Wifferen F, Greuter MJE, Lissenberg-Witte BI, Carvalho B, Meijer GA, Dekker E, Campari C, Garcia M, Rabeneck L, Lansdorp-Vogelaar I, Senore C, Coupé VMH; ICSN Colorectal Cancer Screening Working Group. van Wifferen F, et al. Prev Med. 2022 Nov;164:107187. doi: 10.1016/j.ypmed.2022.107187. Epub 2022 Aug 10. Prev Med. 2022. PMID: 35963311 Free article.
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.
de Klaver W, Wisse PHA, van Wifferen F, Bosch LJW, Jimenez CR, van der Hulst RWM, Fijneman RJA, Kuipers EJ, Greuter MJE, Carvalho B, Spaander MCW, Dekker E, Coupé VMH, de Wit M, Meijer GA. de Klaver W, et al. Among authors: van wifferen f. Ann Intern Med. 2021 Sep;174(9):1224-1231. doi: 10.7326/M20-8270. Epub 2021 Jul 20. Ann Intern Med. 2021. PMID: 34280333
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA, de Klaver W, van Wifferen F, Meiqari L, Bierkens M, Greuter MJE, Carvalho B, van Leerdam ME, Spaander MCW, Dekker E, Coupé VMH, de Wit M, Meijer GA. Wisse PHA, et al. Among authors: van wifferen f. BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2. BMC Cancer. 2022. PMID: 36503495 Free PMC article.
The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study.
Wisse PHA, de Klaver W, van Wifferen F, van Maaren-Meijer FG, van Ingen HE, Meiqari L, Huitink I, Bierkens M, Lemmens M, Greuter MJE, van Leerdam ME, Spaander MCW, Dekker E, Coupé VMH, Carvalho B, de Wit M, Meijer GA. Wisse PHA, et al. Among authors: van wifferen f. Lancet Oncol. 2024 Mar;25(3):326-337. doi: 10.1016/S1470-2045(23)00651-4. Epub 2024 Feb 9. Lancet Oncol. 2024. PMID: 38346438